chr8-1565867-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001346810.2(DLGAP2):c.1415G>A(p.Gly472Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,458,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001346810.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLGAP2 | NM_001346810.2 | c.1415G>A | p.Gly472Glu | missense_variant | 6/15 | ENST00000637795.2 | NP_001333739.1 | |
DLGAP2-AS1 | NR_103863.1 | n.358-129C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLGAP2 | ENST00000637795.2 | c.1415G>A | p.Gly472Glu | missense_variant | 6/15 | 5 | NM_001346810.2 | ENSP00000489774.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 242054Hom.: 0 AF XY: 0.0000229 AC XY: 3AN XY: 131220
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1458034Hom.: 0 Cov.: 33 AF XY: 0.0000166 AC XY: 12AN XY: 724932
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.1175G>A (p.G392E) alteration is located in exon 3 (coding exon 2) of the DLGAP2 gene. This alteration results from a G to A substitution at nucleotide position 1175, causing the glycine (G) at amino acid position 392 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at